Michael D. Banov

Psychiatry

1314 Concord Road Southeast
Smyrna, GA 30080

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Integrating evidence, subject-matter expertise, and consensus in Delphi-based clinical guideline development.

Integrating evidence, subject-matter expertise, and consensus in Delphi-based clinical guideline development.

Journal: Journal of affective disorders

Published: July 12, 2026

Interdisciplinary, Delphi-driven consensus guidelines on the use of intravenous ketamine infusions for depressive disorders from the American Society of Ketamine Physicians, Psychotherapists, and Practitioners (ASKP3).

Interdisciplinary, Delphi-driven consensus guidelines on the use of intravenous ketamine infusions for depressive disorders from the American Society of Ketamine Physicians, Psychotherapists, and Practitioners (ASKP3).

Journal: Journal of affective disorders

Published: March 11, 2026

Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial report.

Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial report.

Journal: The international journal of neuropsychopharmacology

Published: October 21, 2025

The Use of Vagus Nerve Stimulation (VNS) in the Management of Patients with Difficult-to-Treat Major Depressive Disorder (MDD): An Expert Consensus Statement.

The Use of Vagus Nerve Stimulation (VNS) in the Management of Patients with Difficult-to-Treat Major Depressive Disorder (MDD): An Expert Consensus Statement.

Journal: Neuropsychiatric disease and treatment

Published: August 22, 2025

Efficacy of Intravenous Racemic Ketamine on Global Severity and Individual Symptoms of Depression: An Exploratory Retrospective Analysis.

Efficacy of Intravenous Racemic Ketamine on Global Severity and Individual Symptoms of Depression: An Exploratory Retrospective Analysis.

Journal: Journal of clinical psychopharmacology

Published: January 09, 2025

Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trial.

Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trial.

Journal: Brain stimulation

Published: September 20, 2024

Suicide characteristics in patients with marked treatment-resistant major depressive disorder: A RECOVER trial report.

Suicide characteristics in patients with marked treatment-resistant major depressive disorder: A RECOVER trial report.

Journal: Journal of affective disorders

Published: June 25, 2024

Switching to Intranasal Esketamine Maintains the Antidepressant Response to Intravenous Racemic Ketamine Administration: A Case Series of 10 Patients.

Switching to Intranasal Esketamine Maintains the Antidepressant Response to Intravenous Racemic Ketamine Administration: A Case Series of 10 Patients.

Journal: Journal of clinical psychopharmacology

Published: August 19, 2021

Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literature.

Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literature.

Journal: CNS spectrums

Published: July 25, 2019

Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects.

Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects.

Journal: Brain stimulation

Published: May 21, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026